{
  "data": {
    "indicator": {
      "slug": "countries-with-drug-approval",
      "name": "Countries with drug approval",
      "definition": "Number of countries in which a medicine has been granted regulatory approval for a given indication.",
      "unit": "count",
      "scale": "1",
      "default_unit": "count",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "count",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2026-09-10",
        "period_label": "as of 10 Sep 2026",
        "value": 90,
        "scale": "1",
        "unit": "count",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGD9",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGD9",
        "source_org": "Roche",
        "source": {
          "org": "Roche",
          "org_short_name": "Roche",
          "document_title": "U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments",
          "document_url": "https://www.roche.com/media/releases/med-cor-2026-09-10",
          "locator": "About Enspryng (satralizumab)",
          "published_date": "2026-09-10"
        }
      }
    ],
    "available_regions": [
      "GLOBAL"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}